Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7302-7313
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7302
Table 1 Demographical characteristics and clinical data of the patients
Variables
DICH group (n = 26)
Non-DICH group (n = 133)
P value
Age (yr)51.35 ± 12.0853.89 ± 15.170.422
Male gender, n (%)17 (65.38)66 (49.62)0.141
Primary intracranial lesion, n (%)0.679
Traumatic brain injury6 (23.07)43 (17.29)
Intracranial hemorrhage5 (19.23)30 (22.56)
SAH (aneurysm rupture)10 (38.46)29 (21.80)
SAH (AVM rupture)0 (0)0 (0)
Cerebral infarction 0 (0)0 (0)
Tumor2 (7.69)8 (6.02)
Infection 0 (0)4 (3.01)
Primary hydrocephalus3 (11.54)19 (14.29)
Pre-Craniotomy, n (%)9 (34.62)56 (42.11)0.477
Pre-Decompression, n (%)8 (30.77)50 (37.59)0.508
Pre-EVD, n (%)16 (61.54)42 (31.58)0.004a
Pre-Cranioplasty, n (%)2 (7.69)23 (17.29)0.350
LP pressure (mmH2O)141.54 ± 60.93139.42 ± 64.940.878
CSF protein (g/L)0.56 ± 0.460.64 ± 0.600.509
CSF glucose (mmol/L)3.87 ± 1.453.88 ± 1.350.980
CSF nucleated cells (106/L)16.31 ± 20.1611.68 ± 17.150.223
WBC (109/L)8.37 ± 3.107.97 ± 2.820.512
Neutrophils (109/L)5.55 ± 2.975.41 ± 2.630.810
Lymphocyte (109/L)1.89 ± 0.551.75 ± 0.590.237
NLR3.40 ± 2.793.48 ± 2.200.869
RBC (1012/L)4.04 ± 1.543.88 ± 0.690.407
HGB (g/L)112.88 ± 15.44114.71 ± 18.150.631
PLT (109/L)276.31 ± 68.61280.92 ± 102.980.827
PLR160.46 ± 69.01184.02 ± 105.170.275
PT(s)11.64 ± 1.2411.40±1.260.374
INR1.01 ± 0.110.99 ± 0.110.382
Fib (g/L)4.88 ± 7.403.67 ± 1.600.416
Potassium (mmol/L)3.85 ± 0.423.81 ± 0.430.680
Sodium (mmol/L)136.68 ± 5.19138.34 ± 5.300.144
Calcium (mmol/L)2.23 ± 0.122.22 ± 0.170.796
Blood glucose (mmol/L)5.92 ± 1.456.17 ± 2.340.591
SBP (mmHg)137.46 ± 21.35140.14 ± 24.840.609
DBP (mmHg)86.50 ± 13.2285.71 ± 14.080.791
Hypertension, n (%)10 (38.46)49 (36.84)0.876
Other basic disease, n (%)3 (11.54)16 (12.03)1.000
Smoker, n (%)7 (26.92)31 (23.31)0.693
Prior Blood transfusion, n (%)6 (23.08)48 (36.09)0.200
Operation time (min)73.46 ± 34.5874.35 ± 26.860.883
Location of VP shunt, n (%)0.250
Frontal 23 (88.46)101 (75.94)
Occiptal3 (11.54)32 (24.06)
Other VP Complications, n (%)1 (3.85)10 (7.52)0.801
Brain edema around catheter, n (%)15 (57.69)34 (25.56)0.000a
Pre-mRS, n (%)0.281
Low (0-2)8 (30.77)56 (42.11)
High (3-5)18 (69.23)77 (57.89)
Post-mRS, n (%)0.024
Low (0-2)977
High (3-5)1755